Companies / BIO-TECHNE Corp
BIO-TECHNE Corp
Nasdaq: TECHCIK 842023Health CareMINNEAPOLIS, MN
Financials · FY2025
Ownership
156.6M shares outstanding · as of Apr 29, 2026
Ownership
| Insiders | <0.01% | 7,891 |
| Institutions | 109.64% | 171,663,091 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 3
View all →| Insider | % of shares | Shares |
|---|---|---|
McManus MatthewPresident - Diag & Spatial Bio | <0.01% | 7,691 |
Herr Amy E.Director | <0.01% | 200 |
Crouse Steven C.President - Diag & Spatial Bi | — | — |
Institutional holders 595
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.05B | 11.38% | |
| $990.92M | 8.96% | |
| $490.79M | 5.33% | |
| $422.51M | 3.82% | |
| $337.22M | 3.66% | |
| $266.80M | 3.27% | |
| $235.99M | 2.56% | |
| $226.47M | 2.46% | |
| $216.34M | 2.35% | |
| $184.04M | 2.00% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Herr Amy E. Director | Sell | Common Stock | $116.8K | -2K -90.81% | 200 <0.01% of shares | medium |
| Feb 1, 2026 | McManus Matthew Executive | Other | Common Stock | $106.7K | -2K -17.80% | 7,691 <0.01% of shares | low |
| Feb 3, 2026 | Herr Amy E. Director | Other | Common Stock | $1.0K | -16 -0.73% | 2,176 <0.01% of shares | low |
| Feb 3, 2026 | Herr Amy E. Director | Exercise | Common Stock | $0 | +38 +1.76% | 2,192 <0.01% of shares | low |
| Feb 1, 2026 | McManus Matthew Executive | Exercise | Common Stock | $0 | +5K +97.59% | 9,356 <0.01% of shares | low |
| Mar 2, 2026 | Crouse Steven C. Executive | Grant | Stock Option (right to buy) | — | +2K | 1,911 <0.01% of shares | low |
| Mar 2, 2026 | Crouse Steven C. Executive | Grant | Restricted Stock Units | — | +735 | 735 <0.01% of shares | low |
| Mar 2, 2026 | Crouse Steven C. Executive | Grant | Performance Restricted Stock Units | — | +2K | 2,387 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| TECH | — | 09073M104 |